The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.
about
Evidence that dynamin-2 functions as a signal-transducing GTPaseMdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development.MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosisThe gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoterRole of MDM2 and MDMX in DNA repairCancer predisposition caused by elevated mitotic recombination in Bloom miceAbsence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growthBax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesisA novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2Therapeutic considerations for Mdm2: not just a one trick ponyMdm2: the ups and downs.Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesisIdentification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complexDeletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis.The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation.A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleusEndoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3beta.E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.Decreased Mdm2 expression inhibits tumor development and extends survival independent of Arf and dependent on p53.JNK targets p53 ubiquitination and degradation in nonstressed cells.Phosphorylation of serine 18 regulates distinct p53 functions in miceOsteoblast differentiation and skeletal development are regulated by Mdm2-p53 signalingp53 checkpoint ablation exacerbates the phenotype of Hinfp dependent histone H4 deficiency.MdmX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice.Transgenic rescue of ataxia mice reveals a male-specific sterility defect.p53 regulates mtDNA copy number and mitocheckpoint pathway.The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells.Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis.Mdm2 and MdmX as Regulators of Gene ExpressionLack of p53 induction in fish cells by model chemotherapeutics.Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptor signaling.Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation.PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.Activation of liver X receptors prevents statin-induced death of 3T3-L1 preadipocytes.An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis.p53: only ARF the story.
P2860
Q22254607-5FE80DA8-6765-4095-81F8-BCFE52DA3000Q24300985-3C9DD26B-3A0C-41AE-9978-8C590CBC7213Q24301309-D39C56BA-1E39-4203-BA58-E107B4E8A746Q24653488-533332D5-CC41-4EA0-82E0-6B06E192D87BQ28079939-2A096236-024C-47F4-920D-FFD96B72203DQ28139170-9C3AF9E9-7AEE-48BB-A63F-AD41616DF4ECQ28511330-A2A962DA-8435-4BD9-B126-0BBD9F74EA12Q28513038-E4E8C4F3-46FA-46E9-8BCB-0D0B8DB0EC6CQ28588691-2B4D79F5-AF6A-450F-BDE0-DA2980263CF0Q30380490-AB750027-2C07-420C-83C0-3108F28ED4ABQ33594040-ECC5D405-8B8E-4A36-B19F-36B8163D63BBQ33601591-8265A246-3A7F-469B-8377-C6456F825916Q33693493-7C35AE47-6B88-4774-86BE-E2846F49910EQ33835387-0DF3A4F2-9B90-4251-9A97-197019AD0DC9Q33858030-F94E324F-6DDF-4A66-9CA0-D568D05B0881Q33900545-807C6B80-68B6-4AE5-B785-D6D4BC1FC40CQ33944754-CA2A0CB8-3E09-4D9F-84CF-E62C4CDD9DBFQ34097322-8CD7B76A-57CD-43B6-9739-5C3DA5CAFC75Q34284001-406D5F60-E93D-4D84-9EFE-996DD9A72C6DQ34430887-8D25819F-25C4-4029-81CD-1C4C4802A1D8Q35208651-2A3A9AFF-AFCC-49A0-835B-357AE7DE3E73Q35545143-28A62397-01AE-4079-BDEF-C2E0E01586C7Q36117276-6F0F8A7C-105B-4695-B267-F185474465F1Q36180705-07E6C4EF-D7FA-4BB8-9433-20F010CC4063Q36483408-5D724162-F200-42D0-9F9E-DBE6824AD410Q37118359-6074A2D9-8DCA-460A-8772-E4216F68E39BQ37204040-2FDCAF0B-0144-46C8-BB6A-5F1A9EEDB835Q37426771-51C12701-5B98-449A-AEBE-992D94E3B3BFQ38059699-A2CC93E5-EC75-4396-B94E-ADF6440AC6B8Q38059700-4DB7E176-6EE4-49D7-910A-919135AC1033Q39386130-9443E474-5740-4D60-B276-1D3AB4D162A1Q39424924-65B30D44-D586-47D7-B211-565885F1DC63Q40054908-6DAA449C-EA9F-4977-944D-457C4E9DFCE3Q40432782-B0ACC195-F72F-4084-BFB4-7071490AA11FQ40485180-21B061BF-56A6-4917-90C5-A129C80D12E9Q40765673-42222EA9-4D9A-474C-B90D-702830E7E96DQ40928334-0C1E70D4-F941-4659-A5FE-DAD49EA517F2Q42812928-113D1066-8A93-41A2-B48D-F07892651FD4Q42834187-8E06ACB3-7C7C-4702-9E64-6FE50D84F5AAQ45226825-8444B8E7-8609-4388-8397-E5C131ECDBAD
P2860
The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The tumorigenic potential and ...... e presence or absence of Mdm2.
@ast
The tumorigenic potential and ...... e presence or absence of Mdm2.
@en
type
label
The tumorigenic potential and ...... e presence or absence of Mdm2.
@ast
The tumorigenic potential and ...... e presence or absence of Mdm2.
@en
prefLabel
The tumorigenic potential and ...... e presence or absence of Mdm2.
@ast
The tumorigenic potential and ...... e presence or absence of Mdm2.
@en
P2093
P2860
P356
P1476
The tumorigenic potential and ...... e presence or absence of Mdm2.
@en
P2093
A R Hancock
L A Donehower
P2860
P304
14106-14111
P356
10.1073/PNAS.93.24.14106
P407
P577
1996-11-01T00:00:00Z